Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/SPARK-THERAPEUTICS-INC-20708430/news/Spark-Therapeutics-and-Pfizer-Present-Updated-Preliminary-Data-from-Hemophilia-B-Phase-1-2-Trial-Sug-23497033/?utm_source=whatsapp&utm_medium=social&utm_campaign=share